BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Aug 14, 2026; 32(30): 119360
Published online Aug 14, 2026. doi: 10.3748/wjg.119360
Table 2 Baseline demographic and clinicopathological characteristics stratified by serum albumin and neutrophil-to-lymphocyte ratio in the training cohort, n (%)
CharacteristicAlbumin
P value
NLR
P value
Overall (n = 293)
< 38.95 (n = 103)
≥ 38.95 (n = 190)
Overall (n = 293)
< 2.96 (n = 229)
≥ 2.96 (n = 64)
Gender0.9420.314
Female126 (43.0)44 (42.7)82 (43.2)126 (43.0)102 (44.5)24 (37.5)
Male167 (57.0)59 (57.3)108 (56.8)167 (57.0)127 (55.5)40 (62.5)
Age0.0080.757
< 4536 (12.3)8 (7.8)28 (14.7)36 (12.3)27 (11.8)9 (14.1)
> 60155 (52.9)67 (65.0)88 (46.3)155 (52.9)120 (52.4)35 (54.7)
45-60102 (34.8)28 (27.2)74 (38.9)102 (34.8)82 (35.8)20 (31.3)
BMI0.1020.120
< 18.511 (3.8)7 (6.8)4 (2.1)11 (3.8)6 (2.6)5 (7.8)
> 2833 (11.3)14 (13.6)19 (10.0)33 (11.3)26 (11.4)7 (10.9)
18.5-24131 (44.7)47 (45.6)84 (44.2)131 (44.7)99 (43.2)32 (50.0)
24-28118 (40.3)35 (34.0)83 (43.7)118 (40.3)98 (42.8)20 (31.3)
Smoking0.8760.537
No206 (70.3)73 (70.9)133 (70.0)206 (70.3)163 (71.2)43 (67.2)
Yes87 (29.7)30 (29.1)57 (30.0)87 (29.7)66 (28.8)21 (32.8)
Drink0.0610.344
No249 (85.0)93 (90.3)156 (82.1)249 (85.0)197 (86.0)52 (81.3)
Yes44 (15.0)10 (9.7)34 (17.9)44 (15.0)32 (14.0)12 (18.8)
T stage0.0040.033
T1-258 (19.8)12 (11.7)46 (24.2)58 (19.8)52 (22.7)6 (9.4)
T3213 (72.7)78 (75.7)135 (71.1)213 (72.7)162 (70.7)51 (79.7)
T422 (7.5)13 (12.6)9 (4.7)22 (7.5)15 (6.6)7 (10.9)
N stage0.7430.506
N0176 (60.1)61 (59.2)115 (60.5)176 (60.1)136 (59.4)40 (62.5)
N170 (23.9)27 (26.2)43 (22.6)70 (23.9)58 (25.3)12 (18.8)
N247 (16.0)15 (14.6)32 (16.8)47 (16.0)35 (15.3)12 (18.8)
Tumor stage0.0610.048
I48 (16.4)10 (9.7)38 (20.0)48 (16.4)43 (18.8)5 (7.8)
II128 (43.7)51 (49.5)77 (40.5)128 (43.7)93 (40.6)35 (54.7)
III117 (39.9)42 (40.8)75 (39.5)117 (39.9)93 (40.6)24 (37.5)
Differentiated degree0.2480.707
Well15 (5.1)7 (6.8)8 (4.2)15 (5.1)11 (4.8)4 (6.3)
Moderately194 (66.2)66 (64.1)128 (67.4)194 (66.2)155 (67.7)39 (60.9)
Poorly54 (18.4)23 (22.3)31 (16.3)54 (18.4)40 (17.5)14 (21.9)
Undifferentiated30 (10.2)7 (6.8)23 (12.1)30 (10.2)23 (10.0)7 (10.9)
Nerve invasion0.0900.563
No245 (83.6)81 (78.6)164 (86.3)245 (83.6)193 (84.3)52 (81.3)
Yes48 (16.4)22 (21.4)26 (13.7)48 (16.4)36 (15.7)12 (18.8)
Intravascular tumor emboli0.9510.214
No248 (84.6)87 (84.5)161 (84.7)248 (84.6)197 (86.0)51 (79.7)
Yes45 (15.4)16 (15.5)29 (15.3)45 (15.4)32 (14.0)13 (20.3)
CEA0.0460.459
High103 (35.2)44 (42.7)59 (31.1)103 (35.2)78 (34.1)25 (39.1)
Normal190 (64.8)59 (57.3)131 (68.9)190 (64.8)151 (65.9)39 (60.9)
CA19-90.0490.527
High29 (9.9)15 (14.6)14 (7.4)29 (9.9)24 (10.5)5 (7.8)
Normal264 (90.1)88 (85.4)176 (92.6)264 (90.1)205 (89.5)59 (92.2)


Write to the Help Desk